Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
Kimia Farma Tbk.
KAEF
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
4
ROE
0,71%
ROA
0,14%
Book Value
520
Net Income
10,33 M
Total Sales
4,70 T
Total Assets
14,70 T
DER
4.11x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
5,75%
Corporate · Lokal
State Owned Enterprises · Lokal
Tentang Perusahaan
PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Produk & Lini Bisnis
The scope of company’s activities comprises of among others, manufacture and distribution of pharmacy, chemical, biology, healthy, food/drink and apotek.
Dewan Direksi
DP
Djagad Prakasa Dwialam
President Director
LS
Lina Sari
Director
HK
Hadi Kardoko
Director
DR
Disril Revolin Putra
Director
JK
Jasmine Karsono
Director
CH
Chairani Harahap
Director
Dewan Komisaris
SL
Stefan Lohoo
President Commissioner / Indp
MF
Mustofa Fauzi
Independent Commissioner
S
Suprianto
Commissioner
WA
Wiku Adisasmito
Commissioner
FI
Fachmi Idris
Independent Commissioner
DK
Diah Kusumawardani
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
PT Kimia Farma Apotek
Pharmacy
Jakarta 99.99%
PT Kimia Farma Trading & Distribution
Medicine Distribution
Jakarta 99.99%
PT Sinkona Indonesia Lestari
Quinine Factory
Subang 51.00%
PT Kimia Farma Sungwun Pharmacopia
Raw Materials Medicine
Jakarta 75.00%
PT Kimia Farma Dawaa Co. Ltd
Pharmacy and Medicine Distribution
Arab Saudi 60.00%
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
9,2M 6,9M 4,6M 2,3M 0 Sales 2025Q2: Rp 4.369.348.594 Net Income 2025Q2: Rp -95.015.129 2025Q2 Sales 2025Q3: Rp 7.008.211.313 Net Income 2025Q3: Rp -179.731.982 2025Q3 Sales 2025Q4: Rp 9.223.328.056 Net Income 2025Q4: Rp -334.959.336 2025Q4 Sales 2026Q1: Rp 2.030.649.486 Net Income 2026Q1: Rp 74.449.546 2026Q1 Sales 2026Q2: Rp 4.701.690.596 Net Income 2026Q2: Rp 10.325.873 2026Q2
2025 Q2
EPS -34
ROE -5,70%
2025 Q3
EPS -43
ROE -7,38%
2025 Q4
EPS -60
ROE -11,61%
2026 Q1
EPS 54
ROE 10,06%
2026 Q2
EPS 4
ROE 0,71%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 4,70 T 10,33 M 14,70 T 2,90 T 4 0,71% 4.11x
2026 Q1 2,03 T 74,45 M 14,36 T 2,96 T 54 10,06% 3.88x
2025 Q4 9,22 T -334,96 M 14,18 T 2,89 T -60 -11,61% 3.97x
2025 Q3 7,01 T -179,73 M 14,91 T 3,25 T -43 -7,38% 3.61x
2025 Q2 4,37 T -95,02 M 14,97 T 3,33 T -34 -5,70% 3.51x
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 420 520 0,14%
2026 1 462 532 2,07%
2025 4 515 518 -2,36%
2025 3 540 583 -1,61%
2025 2 675 599 -1,27%
Data diperbarui pada: 2026-05-12 10:55:29